Modulating the strength and threshold of NOTCH oncogenic signals by mir-181a-1/b-1.
Oncogenes, which are essential for tumor initiation, development, and maintenance, are valuable targets for cancer therapy. However, it remains a challenge to effectively inhibit oncogene activity by targeting their downstream pathways without causing significant toxicity to normal tissues. Here we...
Main Authors: | Rita Fragoso, Tin Mao, Song Wang, Steven Schaffert, Xue Gong, Sibiao Yue, Richard Luong, Hyeyoung Min, Yumi Yashiro-Ohtani, Mark Davis, Warren Pear, Chang-Zheng Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC3415433?pdf=render |
Similar Items
-
Pre-miRNA loop nucleotides control the distinct activities of mir-181a-1 and mir-181c in early T cell development.
by: Gwen Liu, et al.
Published: (2008-01-01) -
Discovery of the Oncogenic Parp1, a Target of bcr-abl and a Potential Therapeutic, in mir-181a/PPFIA1 Signaling Pathway
by: Chunming Gu, et al.
Published: (2019-06-01) -
miR-181a initiates and perpetuates oncogenic transformation through the regulation of innate immune signaling
by: Matthew Knarr, et al.
Published: (2020-06-01) -
Despite high levels of expression in thymic epithelial cells, miR-181a1 and miR-181b1 are not required for thymic development.
by: Heather E Stefanski, et al.
Published: (2018-01-01) -
MicroRNA-181a Functions as an Oncogene in Gastric Cancer by Targeting Caprin-1
by: Qiang Lu, et al.
Published: (2019-01-01)